Abstract
Heterocycle-fused azepines are discussed as potent 5-HT2C receptor agonists with excellent selectivity over 5-HT2B agonism. Synthesis and structure activity relationships are outlined for a series of bicyclic pyridazino[3,4-d]azepines. By comparison with earlier published work, in vitro assays predict a high probability for achieving CNS penetration for a potent and selective compound 15a, a pre-requisite to achieve in vivo efficacy.
Keywords:
5-HT(2C) receptor agonists; CNS penetration; Obesity; Pyridazino[3,4-d]azepines; Urinary incontinence.
Copyright © 2016 Elsevier Ltd. All rights reserved.
MeSH terms
-
ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics
-
ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
-
Animals
-
Azepines / chemical synthesis
-
Azepines / chemistry*
-
Azepines / metabolism
-
Dogs
-
Drug Design*
-
Humans
-
Madin Darby Canine Kidney Cells
-
Protein Binding
-
Pyridazines / chemistry*
-
Receptor, Serotonin, 5-HT2B / chemistry
-
Receptor, Serotonin, 5-HT2B / metabolism
-
Receptor, Serotonin, 5-HT2C / chemistry
-
Receptor, Serotonin, 5-HT2C / metabolism*
-
Serotonin 5-HT2 Receptor Agonists / chemical synthesis*
-
Serotonin 5-HT2 Receptor Agonists / chemistry
-
Serotonin 5-HT2 Receptor Agonists / metabolism
-
Structure-Activity Relationship
Substances
-
ATP Binding Cassette Transporter, Subfamily B, Member 1
-
Azepines
-
Pyridazines
-
Receptor, Serotonin, 5-HT2B
-
Receptor, Serotonin, 5-HT2C
-
Serotonin 5-HT2 Receptor Agonists
-
pyridazine